Efficacy and acceptability of two monophasic oral contraceptives containing ethinylestradiol and either desogestrel or gestodene

HW Halbe, NR De Melo, L Bahamondes… - … European Journal of …, 1998 - Taylor & Francis
Objective To assess the contraceptive efficacy, cycle control and acceptability of two
monophasic oral contraceptives containing either 30 µg ethinylestradiol plus 150 µg …

A comparison of the cycle control and tolerability of two ultra low-dose oral contraceptives containing 20 μg ethinylestradiol and either 150 μg desogestrel or 75 μg …

D Serfaty, ML Vree - The European Journal of Contraception & …, 1998 - Taylor & Francis
Objective To compare the cycle control and tolerability of two oral contraceptives containing
20 μg ethinylestradiol and either 150 μg desogestrel or 75 μg gestodene. Methods A …

A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 μg ethinylestradiol/75 μg gestodene and 20 μg ethinylestradiol …

J Endrikat, MA Jaques, M Mayerhofer, C Pelissier… - Contraception, 1995 - Elsevier
The aim of this study was to compare contraceptive reliability, cycle control and tolerance of
an oral contraceptive containing 20 μg ethinylestradiol and 75 μg gestodene, with a …

A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 μg ethinylestradiol/75 μg gestodene and 30 μg ethinylestradiol/75 …

J Endrikat, U Müller, B Düsterberg - Contraception, 1997 - Elsevier
The aim of this study was to compare contraceptive reliability, cycle control, and tolerance of
an oral contraceptive containing 20 μg ethinylestradiol (EE2) and 75 μg gestodene (GSD) …

Latin American experience with two low–dose oral contraceptives containing 30 μg ethinylestradiol/75 μg gestodene and 20 μg ethinylestradiol/150 μg desogestrel

S Bassol, A Alvarado, C Celis, MC Cravioto, O Peralta… - Contraception, 2000 - Elsevier
The objective of this study was to compare cycle control, efficacy and tolerance of an oral
contraceptive containing 20 μg ethinylestradiol and 150 μg desogestrel with a preparation …

Clinical comparison of monophasic oral contraceptive preparations of gestodene/ethinyl estradiol and desogestrel/ethinyl estradiol

Latin American Oral Contraceptive Study Group - Contraception, 1994 - Elsevier
The efficacy, cycle control, subjective complaints, and safety of monophasic preparations of
the oral contraceptives containing gestodene 75 mcg plus ethinyl estradiol 30 mcg versus …

Comparative study on the acceptability of two modern monophasic oral contraceptive preparations: 30 μg ethinyl estradiol combined with 150 μg desogestrel or 75 μg …

L Zichella, C Sbrignadello, A Tomassini… - Advances in …, 1999 - Springer
Cycle control and tolerability of two monophasic oral contraceptive pills containing 30 μg
ethinyl estradiol (EE) with either 150 μg desogestrel (DSG) or 75 μg gestodene (GSD) were …

Multicenter trial of two monophasic oral contraceptives containing 30 mcg ethinylestradiol and either desogestrel or gestodene in Thai women

S Koetsawang, C Charoenvisal… - …, 1995 - contraceptionjournal.org
The efficacy and acceptability of two third generation oral contraceptives in Thai women
were evaluated in a prospective, open, group-comparative, randomized, multicenter trial of …

A 13-month multicenter clinical experience of a low-dose monophasic oral contraceptive containing 20 μg ethinylestradiol and 75 μg gestodene in Latin American …

S Bassol, G Alvarado, RG Arreola, C Celis-Gonzalez… - Contraception, 2003 - Elsevier
This prospective, multicenter study was conducted to evaluate the contraceptive reliability,
cycle control and tolerability of a 21-day oral contraceptive regimen containing 20 μg …

Multicenter study of the efficacy, cycle control and tolerability of a phasic desogestrel-containing oral contraceptive

H Ferguson, ML Vree, J Wilpshaar… - The European Journal of …, 2000 - Taylor & Francis
Objective To investigate the efficacy, cycle control and tolerability of a phasic oral
contraceptive containing ethinylestradiol 35/30/30 μg and desogestrel 50/100/150 μg …